Article

Found 1 results
Filters: Keyword is prostate cancer and Author is Xue Liang  [Clear All Filters]
2022
Liang X, Lan Z, Huang Y, Jiang G, Liu T. Formononetin inhibits metastatic potential of human prostate cancer cells via upregulating EGR1. Pharmacognosy Magazine [Internet]. 2022;18(80):932-939. http://www.phcog.com/text.asp?2022/18/80/932/361754PDF icon PDF (3.58 MB)